Abnormal adrenocorticotropic hormone (acth) stimulation test after Oclacitinib (Apoquel) in dogs

21 reports to the FDA describe abnormal adrenocorticotropic hormone (acth) stimulation test in dogs given Oclacitinib. That is 0.1% of all reports for this medicine, compared with 0.1% across reports for all dog medicines.

21Reports

43%Marked serious

4.8%Recovered

4.8%Died or euthanised

195 daysTypical onset

How soon it started

Same day

0 0.0%

1–2 days

0 0.0%

3–7 days

0 0.0%

1–4 weeks

1 6.7%

Over a month

14 93%

How the animals did

Recovered

1 4.8%

Still unwell when reported

8 38%

Euthanised

1 4.8%

Not known

11 52%

Problems reported at the same time

12 57%

10 48%

6 29%

5 24%

5 24%

5 24%

4 19%

4 19%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

12+ years

About this medicine

Oclacitinib controls itching from allergies (tablet, a JAK inhibitor).

Products with this ingredient include Apoquel. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Oclacitinib cause abnormal adrenocorticotropic hormone (acth) stimulation test in dogs?: 21 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?: In half of the reports with dates, it started within 195 days of the first dose.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

All reported side effects of Oclacitinib in dogs · Medicines most reported with abnormal adrenocorticotropic hormone (acth) stimulation test